Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
Recruiting
Observational Study
Autoimmune Hepatitis
Liver Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- University of Milano Bicocca · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown.
This is an observational, retrospective and prospective, multicent…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All AIH patients living in Italy and aged at least 1 year can be included in the database.
* Willing and able to give informed consent prior to any study specific procedure being
* Diagnosis of AIH according to the most recent published guidelines (EASL)
Exclusion Criteria:
…
Contacts